Funder
High-level Hospital Construction Project
fundamental research funds for the central universities
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference57 articles.
1. Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet 388:73–85. https://doi.org/10.1016/S0140-6736(16)00141-0
2. Lai E, Puzzoni M, Ziranu P et al (2019) New therapeutic targets in pancreatic cancer. Cancer Treat Rev 81:101926. https://doi.org/10.1016/j.ctrv.2019.101926
3. Parkin A, Man J, Chou A, Nagrial AM, Samra J, Gill AJ, Timpson P, Pajic M (2018) The evolving understanding of the molecular and therapeutic landscape of pancreatic ductal adenocarcinoma. Diseases. https://doi.org/10.3390/diseases6040103
4. Bazhin AV, Shevchenko I, Umansky V, Werner J, Karakhanova S (2014) Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. Cancer Immunol Immunother CII 63:59–65. https://doi.org/10.1007/s00262-013-1485-8
5. Elaileh A, Saharia A, Potter L, Baio F, Ghafel A, Abdelrahim M, Heyne K (2019) Promising new treatments for pancreatic cancer in the era of targeted and immune therapies. Am J Cancer Res 9:1871–1888